Otherside Farms

JANUARY 25, 2019

Lead author Dr. Tim England, honorary consultant stroke physician at the University of Nottingham and Royal Derby Hospital, presented the findings at this week’s annual UK Stroke Forum conference. The data are guiding the next steps in experimental stroke in order to be able to progress onto initial safety assessments in a clinical trial.”.

Clinical Trials 74

Clinical Trials Marijuana Cannabinoids Data 74

Project CBD

NOVEMBER 11, 2023

So just on safety alone, it’s worth using it. We rate levels of evidence, and a high level may be a controlled randomized clinical trial (RCT), but there are also observational studies. I think it’s more useful when THC is also present. I think it’s more useful when THC is also present.

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 40

Epilepsy Pharmaceutical Data Clinical Trials 40

Cannabis Law Report

JULY 24, 2021

The groundbreaking progress that we’ve seen from the Multidisciplinary Association for Psychedelic Studies (MAPS) in its Phase 3 clinical trials of MDMA-assisted psychotherapy for Post-Traumatic Stress Disorder (PTSD), including receiving Breakthrough Therapy Designation from the Food and Drug Administration (FDA), shows great promise to date.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Cannabis Law Report

AUGUST 12, 2021

Phase IIb clinical trial of COMP360 psilocybin therapy for TRD close to completion. Danielle Schlosser PhD appointed Senior Vice-President, Clinical Innovation, to lead therapist research and training, bringing her clinical experience in behavioural health and expertise in digital health innovation. Business highlights.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Systematic review and meta-analysis were performed to examine the efficacy and safety of MCs treatment among children.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

OCTOBER 15, 2021

At ASHG, Goldfinch Bio will give an oral presentation showcasing insights revealed by its Kidney Genome Atlas (KGA). At ASHG, Goldfinch Bio will give an oral presentation showcasing insights revealed by its Kidney Genome Atlas (KGA). Both meetings are being held virtually. President and Chief Executive Officer of Goldfinch Bio.

Clinical Trials 40

Clinical Trials Research and Development Data Patients 40

The Joint Blog

APRIL 21, 2020

This is according to a study published in the Journal of Clinical Medicine Research and epublished by the U.S. For the study researchers with the Nordic Cannabis Research Institute in Denmark reviewed 25 clinical trials assessing the safety and efficacy of CBD in various populations. National Institute of Health.

Clinical Trials 52

Clinical Trials CBD Safety Patients 52

Veriheal

MAY 16, 2022

Following the successful experiment into the potential safety and efficacy of using ketamine for Parkinson’s patients, the university proceeded to sign an exclusive licensing partnership with Pharmather Inc. , At the current time, researchers are busy carrying out a small-scale Phase I clinical trial into ketamine for PD.

Research and Development 19

Research and Development Treatment Clinical Trials Patients 19

MedicalJane

MAY 21, 2020

Researchers at The University of New Mexico (UNM) have conducted a series of recent studies testing the effectiveness and safety of consuming cannabis, but this is the first study they have conducted measuring the therapeutic potential of hemp oil with low THC levels.

Oil 100

Oil Hemp Extraction Clinical Trials 100

Cannabis Law Report

AUGUST 23, 2021

Details of a presentation to investors via the InvestorMeet Platform will be announced shortly. At the end of the programme, Evotec will provide the Company with a submission-ready regulatory document which will be used for submissions to regulatory agencies, as well as drug-batch approved and ready for First Time in Human clinical trials.

Cannabinoids 98

Cannabinoids Research and Development Clinical Trials Packaging 98

Cannabis Law Report

SEPTEMBER 22, 2021

Investors are invited to view the presentation and the panel here: link. Can-Fite Corporate Presentation. These drugs have an excellent safety profile with experience in over 1,500 patients in clinical studies to date. PETACH TIKVA, Israel–(BUSINESS WIRE)– Can-Fite BioPharma Ltd. Time: 11:55 am – 12:35 pm ET.

Clinical Trials 40

Clinical Trials Treatment Business Events 40

MMJ Recs

JULY 9, 2024

Living with MS can significantly impact a person’s quality of life, requiring ongoing medical management and support to address the physical, emotional, and social challenges it presents. Some clinical trials have shown that cannabinoids, particularly THC and CBD, effectively reduce muscle spasticity and pain in MS patients.

Marijuana 111

Marijuana Treatment Cannabinoids Patients 111

The Cannigma

AUGUST 31, 2021

A 2018 research paper in the International Journal of Drug Policy analyzed in-depth interviews carried out with 24 Israeli physicians working in pain medicine, oncology, and family medicine, and found that “physicians discussed contrasting narratives of cananbi, presenting it as both a medicine and non-medicine.”

Education 105

Education Clinical Trials Medicine Policy 105

Cannabis Law Report

JANUARY 26, 2022

The designation is intended to accelerate the timeline for approval of innovative medicines for treatment of life-threatening conditions or those which present a significant patient or public health need. No drug is without risks, so clinical trials have included careful investigation of possible adverse effects.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

Cannabis Law Report

NOVEMBER 1, 2021

These drugs have an excellent safety profile with experience in over 1,500 patients in clinical studies to date. Namodenoson has also shown proof of concept to potentially treat other cancers including colon, prostate, and melanoma. For more information please visit: www.can-fite.com. Forward-Looking Statements.

Clinical Trials 40

Clinical Trials Research and Development Treatment Business 40

Cannabis Law Report

MARCH 1, 2022

Focus will be on IND/CTA filings and associated interactions, and may include safety reports, protocols, information amendments, responses to requests for information, IND Annual Reports/DSURs, and new investigator amendments. Knowledge of Canadian, Australian and New Zealand clinical trial regulations and procedures is a plus.

Clinical Trials 52

Clinical Trials Environment Pharmaceutical Programs 52

Cannabis Law Report

OCTOBER 2, 2021

Focus will be on IND/CTA filings and associated interactions, and may include safety reports, protocols, information amendments, responses to requests for information, IND Annual Reports/DSURs, and new investigator amendments. Knowledge of Canadian, Australian and New Zealand clinical trial regulations and procedures is a plus.

Clinical Trials 52

Clinical Trials Environment Pharmaceutical Programs 52

The Cannigma

JULY 1, 2022

The highest quality form of scientific research, in terms of whether the results provide predictive power (which is what science is all about), is the placebo controlled, double blind, randomized clinical trial. Non-clinical research can help answer questions regarding safety and risk in very powerful ways.

Research and Development 124

Research and Development Data THC Clinical Trials 124

MMJ Recs

JULY 11, 2024

In this article, we explore the role of medical marijuana in addressing insomnia, examining its effectiveness, safety considerations, legal aspects, and practical considerations for patients and healthcare providers. Medical marijuana is a potential treatment for insomnia, and it offers an alternative to traditional pharmaceuticals.

Sleep 111

Sleep Treatment Research and Development Therapy 111

LifeCannMD

MAY 27, 2025

Now, with 1.5mg of a balanced THC:CBD tincture twice daily, he’s giving presentations at work and actually enjoying social events again. Take James, a 34-year-old software developer who came to me with severe social anxiety after obtaining his marijuana card. Traditional medications left him feeling like a zombie.

Microdosing 52

Microdosing Research and Development Sleep Chronic Pain 52

Cannabis Law Report

JULY 30, 2019

Cannabis-based products will be allowed to bypass usual processes required for medicines in New Zealand and go directly onto the market without any proof of safety or effectiveness. From trial to market. Finally, the medicine moves into “efficacy” trials. These trials confirm safety and, importantly, establish effectiveness.

Medicine 40

Medicine Clinical Trials Safety Access 40

The Joint Blog

JANUARY 23, 2020

.” The systematic review of the literature “was conducted during 2019, assessing the data from all case studies and clinical trials involving medicinal cannabis or plant-derived isolates for all major psychiatric disorders (neurological conditions and pain were omitted).”

Clinical Trials 52

Clinical Trials Marijuana Sleep Cannabinoids 52

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

APRIL 13, 2022

Complementary businesses combine to create a preeminent North American platform with operations spanning 13 wellness clinics, four research sites and one bioanalytical laboratory. Hosting clinical trials for MDMA ( MAPS Public Benefit Corporation), psilocybin (the Usona Institute), LSD (MindMed) and ketamine (the University of Utah ).

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

MMJ Recs

NOVEMBER 30, 2023

While anecdotal evidence and individual success stories have sparked interest in using MMJ for seizure control, scientific research plays a crucial role in establishing its safety and efficacy. Clinical trials and studies are underway to examine the potential benefits and risks of MMJ as a treatment option for epilepsy.

Epilepsy 105

Epilepsy Treatment Patients Strains 105

Cannabis Law Report

JUNE 14, 2022

At the launch event, we will present PAREA Call to Action with key priority areas that should be addressed to make sure that the emerging psychedelic-assisted therapies will reach those who need them in Europe”. Ahead of the launch, PAREA Chair Prof.

Access 52

Access Therapy Clinical Trials Treatment 52

Cannabis Law Report

MARCH 29, 2020

This “zero recall” standard, the team said, was attributed to the fact that their cannabis product standards with regard to food safety and health was high and involved documentation of over 100 pages. . These are the responsibility of the manufacturer. Setting Standards for Cannabis Research Studies .

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

Cannabis Law Report

JUNE 10, 2021

The Traffic Safety Culture Index is an annual survey with national scope and multiple measures relevant to driving after marijuana use. Because THC presence is an imperfect proxy for impairment [ 10 ], driving data may be limited in clarifying what traffic safety risks, if any, are associated with permissive marijuana policies.

Policy 45

Policy Safety Marijuana Data 45

MMJ Recs

JULY 17, 2024

Clinical trials have highlighted the efficacy of medical marijuana in managing pain, suggesting it as a potential alternative or adjunct to traditional pain medications. Pain Management THC and CBD in medical marijuana have demonstrated analgesic properties, offering relief from chemotherapy-induced neuropathic pain and inflammation.

Marijuana 52

Marijuana Treatment Patients Therapy 52

Cannabis Law Report

JANUARY 13, 2020

Justin Gover, GW’s Chief Executive Officer expects to discuss these updates as part of a webcast presentation at the 38 th Annual J.P. Continue to explore CBDV in autism through a combination of open-label and investigator-led placebo controlled clinical trials with data from one or more of these programs in 2020.

Pharmaceutical 51

Pharmaceutical Clinical Trials Research and Development Programs 51

MMJ Recs

JULY 5, 2024

It is one of over 100 cannabinoids present in cannabis, and it is responsible for the “high” or euphoric sensation typically associated with cannabis use. Numerous clinical trials are underway to further investigate THC’s efficacy, safety, and potential interactions with other medications as well.

THC 52

THC Research and Development Chronic Pain Cannabinoids 52

Cannabis Law Report

OCTOBER 26, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, announced today that Chris Chapman, M.D., said Dr. Chapman is a seasoned executive and global medical expert with extensive experience in designing and clinical trial protocols and conducting clinical trials.

Pharmaceutical 40

Pharmaceutical Clinical Trials Research and Development Therapy 40

Cannabis Law Report

NOVEMBER 26, 2021

With the anticipated launch of Pfizer’s oral COVID-19 antiviral drug candidate, Can-Fite has made a strategic decision to end its COVID-19 program and to focus its resources on its other clinical programs, all in advanced clinical trials. Financial Results. Revenues for the nine months ended September 30, 2021 were $0.65

Clinical Trials 40

Clinical Trials Research and Development Treatment Data 40

MMJ Recs

NOVEMBER 20, 2023

Researchers have been conducting clinical studies to investigate the safety and efficacy of cannabinoid-based treatments. CBD’s anti-seizure properties, demonstrated through clinical trials, have made it a game-changer in the epilepsy field. The outcomes of these studies have had a profound impact on patient care.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

TheAnswerPage

JANUARY 11, 2022

For example, most, if not all, states have legalized the use of medical marijuana to treat specific health conditions for which there is no or only poor quality clinical evidence of efficacy and safety. to take a medical marijuana course that reviews the endocannabinoid system and the therapeutic use of marijuana.

Patients 98

Patients Education Marijuana Therapy 98

The Cannigma

JUNE 15, 2021

But the main issue with hemp derived products and their safety is less about the CBD and more about everything else in them. The main safety issues with CBD are drug interactions, and unsafe manufacturing processes due to the unregulated environment. . But that doesn’t make it completely risk free. Kevin McGovern/Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122